Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Forbes-Meditech, FMI,V -- Ignore unavailable to you. Want to Upgrade?

To: SG who wrote (409)	10/26/2007 5:38:12 PM
From: Tadsamillionaire	Read Replies (1) \| Respond to of 430

There phase 2 trials for FM-VP4 did not achieve the Company's established goal of a 15% back in December 06. The PPS dropped by half. I have been watching the stock for some time, and when they came out with the new boost in revenue, I figured it was beat up enough for a turn around. But I buy specific situations where i believe the company is a turn around, or has contacts and is connected. Some I take as tax losses some like FRPT, ABRX CYBR, I make some money on Since then they have announced Forbes Medi-Tech Inc.: Reducol'TM' Press Conference Held in France Supporting Reducol'TM' Product Launch with World's Second Largest Food Distributor, Carrefour Group Wednesday December 13, 2006 8:00 am ET Carrefour Group The second-largest retailer in the world and the European leader, the Carrefour Group has worked for more than forty years to establish its position as the daily partner of millions of customers in Europe, Asia and Latin America. biz.yahoo.com and Forbes Medi-Tech Expands Reducol'TM' Sales in Portugal With the Addition of Modelo Continente to Customer List Thursday January 18, 2007 8:00 am ET Reducol'TM' Based Products Sold Through Country's Leading Retailers biz.yahoo.com Forbes Medi-Tech Announces Next Steps in Pharmaceutical Development and Corporate Restructuring Monday February 12, 2007 8:00 am ET Company Eliminates Non-Core R&D Expenses and Extends Working Capital to Mid 2008 biz.yahoo.com and Forbes Medi-Tech Inc.: Reducol(TM) Product Range Expanded With Cholesterol-Lowering Rye Bread Wednesday May 23, 8:00 am ET Kesko Launch Creates New Opportunities in European Functional Food Market biz.yahoo.com and Forbes Medi-Tech Inc.: Taiwan's Largest Drink Producer Launches Reducol(TM)-Based Milk Drink Tuesday August 7, 8:00 am ET biz.yahoo.com